Table 3 Objective response rate, duration of response, PFS and survival data
Variable | GEM, n (%) | GEM+CI 5-FU, n (%) |
|---|---|---|
Evaluable patients | 48 | 43 |
CR | — | — |
PR | 4 (8%) | 5 (11%) |
(95% confidence interval) | (0.5–16%) | (2–22%) |
SD | 14 (29%) | 12 (28%) |
PR+SD | 18 (37%) | 17 (39%) |
PD | 30 (63%) | 26 (61%) |
Median duration response (range) | 34 weeks (25–101) | 26 weeks (16–46) |
Median PFS (range) | 14 weeks (2–65) | 18 weeks (4–51) |
Median OS (range) | 31 weeks (1–101) | 30 weeks (1–101) |
